Development of anti-‐Leishmaniavaccines…
259
18 Duthie, M. S.; Raman, V. S.; Piazza, F. M.; Reed, S. G. The development and clinical
evaluationof second-‐generation leishmaniasisvaccines. Vaccine
30
, 134-‐141(2012).
19 Singh, B.; Sundar, S. Leishmaniasis: Vaccine candidates and perspectives. Vaccine
30
,
3834-‐3842(2012).
20 Raman, V. S.;Duthie,M. S.; Fox, C. B.;Matlashewski, G.; Reed, S. G. Adjuvants for
Leishmania
vaccines: frommodels toclinical application. Frontiers in Immunology
3
, 144(2012).
21 Kedzierski, L. Leishmaniasis. HumanVaccines
7
, 1204-‐1214(2011).
22 Okwor, I.; Mou, Z.; Liu, D.; Uzonna, J. Protective immunity and vaccination against
cutaneous leishmaniasis. Frontiers in Immunology
3
, 128(2012).
23 McConville, M. J.; Blackwell, J. M. Developmental changes in the glycosylated
phosphatidylinositols of
Leishmania donovani
. Characterization of the promastigote and
amastigoteglycolipids. Jornal ofBiological Chemistry
266
, 15170-‐15179(1991).
24 Pimenta, P. F.; Saraiva, E. M.; Sacks, D. L. The comparative fine structure and surface
glycoconjugate expression of three life stages of
Leishmania major
. Experimental
Parasitology
72
, 191-‐204(1991).
25 Shreffler, W. G.; Burns, J. M. Jr.; Badaro, R.; Ghalib, H. W.; Button, L. L.; McMaster, W. R.;
Reed, S. G. Antibody responses of visceral leishmaniasis patients to gp63, amajor surface
glycoprotein of
Leishmania
species. The Journal of Infectious Diseases
167
, 426-‐430
(1993).
26 Morales, G.; Carrillo, G.; Requena, J.M.; Guzman, F.; Gomez, L. C.; Patarroyo,M. E.; Alonso, C.
Mapping of the antigenic determinants of the
Leishmania infantum
gp63 protein
recognized by antibodies elicited during canine visceral leishmaniasis. Parasitology
114
,
507-‐516(1997).
27 Soto, M.; Ramirez, L.; Pineda, M. A.; Gonzalez, V. M.; Entringer, P. F.; Indiani deOliveira, C.;
Nascimento, I. P.; Souza, A. P.; Corvo, L.; Alonso, C.; Brodskyn, C.; Barral, A.; Barral-‐Netto,
M.; Iborra, S. Searching genes encoding
Leishmania
antigens for diagnosis and protection.
ScholarlyResearchExchange
2009
, ID173039(2009).
28 Cote-‐Sierra, J.; Bredan, A.; Toldos, C. M.; Stijlemans, B.; Brys, L.; Cornelis, P.; Segovia, M.; de
Baetselier, P.; Revets, H. Bacterial lipoprotein-‐based vaccines induce tumor necrosis
factor-‐dependent type 1 protective immunity against
Leishmania major
. Infection and
Immunity
70
, 240-‐248(2002).
29 Yang, D. M.; Rogers, M. V.; Liew, F. Y. Identification and characterizationof host-‐protective
T-‐cell epitopes of a major surface glycoprotein (gp63) from
Leishmania major.
Immunology
72
, 3-‐9(1991).
30 Rivas, L.; Kahl, L.; Manson, K.; McMahon-‐Pratt, D. Biochemical characterization of the
protective membrane glycoprotein GP46/M-‐2 of
Leishmania amazonensis
. Molecular and
Biochemical Parasitology
47
, 235-‐243(1991).
31 Boceta, C.; Alonso, C.; Jimenez-‐Ruiz, A. Leucine rich repeats are the main epitopes in
Leishmania infantum
PSA during canine and human visceral leishmaniasis. Parasite
Immunology
22
, 55-‐62(2000).
32 Berberich, C.; Requena, J. M.; Alonso, C. Cloning of genes and expression and antigenicity
analysis of the
Leishmania infantum
KMP-‐11 protein. Experimental Parasitology
85
, 105-‐
108(1997).
33 Ramirez, J. R.; Berberich, C.; Jaramillo, A.; Alonso, C.; Velez, I. V. Molecular and antigenic
characterizationof the
Leishmania (Viannia) panamensis
kinetoplastidmembraneprotein-‐
11.Memoriasdo InstitutoOswaldoCruz.
93
, 247-‐254(1998).
34 Passos, S.; Carvalho, L. P.; Orge, G.; Jeronimo, S. M.; Bezerra, G.; Soto, M.; Alonso, C.;
Carvalho, E. M. Recombinant
Leishmania
antigens for serodiagnosis of visceral
leishmaniasis. Clinical andDiagnosticLaboratory Immunolology
12
, 1164-‐1167(2005).
35 Carvalho, L. P.; Passos, S.; Dutra, W. O.; Soto, M.; Alonso, C.; Gollob, K. J.; Carvalho, E. M.;
Ribeiro de Jesus, A. Effect of LACK and KMP11 on IFN-‐gamma production by peripheral
blood mononuclear cells from cutaneous and mucosal leishmaniasis patients.
Scandinavian Journal of Immunology
61
, 337-‐342(2005).
36 Carrillo, E.; Crusat, M.; Nieto, J.; Chicharro, C.; Thomas M, C.; Martinez, E.; Valladares, B.;
Cañavate, C.; Requena, J. M.; Lopez, M. C.; Alvar, J.; Moreno, J. Immunogenicity of HSP-‐70,
KMP-‐11 and PFR-‐2 leishmanial antigens in the experimental model of canine visceral
leishmaniasis. Vaccine
26
, 1902-‐1911(2008).
37 Basu, R.; Bhaumik, S.; Basu, J. M.; Naskar, K.; De, T.; Roy, S. Kinetoplastid membrane
protein-‐11 DNA vaccination induces complete protection against both pentavalent
